These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30143352)

  • 21. Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.
    Evageliou N; Renfro LA; Geller J; Perlman E; Kalapurakal J; Paulino A; Dix D; Eklund MJ; Murphy AJ; Romao RLP; Ehrlich PF; Varela CR; Vallance K; Fernandez CV; Dome JS; Mullen EA
    Cancer; 2024 Mar; 130(5):792-802. PubMed ID: 37902955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
    Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
    J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A third Wilms' tumor locus on chromosome 16q.
    Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
    Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between TP53 Mutation and Prognosis in Wilms Tumor: A Meta-Analysis.
    Lizhi L; Rongdong H; Shaohua H; Yingquan K; Huihuang X; Shan L; Kunbin T; Di X
    Fetal Pediatr Pathol; 2021 Dec; 40(6):653-662. PubMed ID: 32066305
    [No Abstract]   [Full Text] [Related]  

  • 27. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene.
    Yeh A; Wei M; Golub SB; Yamashiro DJ; Murty VV; Tycko B
    Genes Chromosomes Cancer; 2002 Oct; 35(2):156-63. PubMed ID: 12203779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.
    Wittmann S; Zirn B; Alkassar M; Ambros P; Graf N; Gessler M
    Genes Chromosomes Cancer; 2007 Feb; 46(2):163-70. PubMed ID: 17099873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemizygous deletions of chromosome band 16q24 in Wilms tumor: detection by fluorescence in situ hybridization.
    Shearer PD; Valentine MB; Grundy P; DeCou JM; Banavali SD; Komuro H; Green DM; Beckwith JB; Look AT
    Cancer Genet Cytogenet; 1999 Dec; 115(2):100-5. PubMed ID: 10598141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis.
    Austruy E; Candon S; Henry I; Gyapay G; Tournade MF; Mannens M; Callen D; Junien C; Jeanpierre C
    Genes Chromosomes Cancer; 1995 Dec; 14(4):285-94. PubMed ID: 8605117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of FFPE based Wilms' Tumor samples through copy number and somatic mutation related Molecular Inversion Probe Based Array.
    Singh N; Sahu DK; Goel M; Kant R; Gupta DK
    Gene; 2015 Jul; 565(2):295-308. PubMed ID: 25913740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.
    Gratias EJ; Jennings LJ; Anderson JR; Dome JS; Grundy P; Perlman EJ
    Cancer; 2013 Nov; 119(21):3887-94. PubMed ID: 23983061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
    Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
    Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group.
    Bown N; Cotterill SJ; Roberts P; Griffiths M; Larkins S; Hibbert S; Middleton H; Kelsey A; Tritton D; Mitchell C
    Med Pediatr Oncol; 2002 Jan; 38(1):11-21. PubMed ID: 11835232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters.
    Klamt B; Schulze M; Thäte C; Mares J; Goetz P; Kodet R; Scheulen W; Weirich A; Graf N; Gessler M
    Genes Chromosomes Cancer; 1998 Aug; 22(4):287-94. PubMed ID: 9669666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
    Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
    Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
    Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity analysis at different chromosome regions in Wilms tumor confirms 1p allelic loss as a marker of worse prognosis: a study from the Italian Association of Pediatric Hematology and Oncology.
    Spreafico F; Gamba B; Mariani L; Collini P; D'Angelo P; Pession A; Di Cataldo A; Indolfi P; Nantron M; Terenziani M; Morosi C; Radice P; Perotti D;
    J Urol; 2013 Jan; 189(1):260-6. PubMed ID: 23174227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
    Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.